KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Short-term Investments (2019 - 2025)

LifeMD (LFMD) has disclosed Short-term Investments for 7 consecutive years, with $320000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments rose 685.03% year-over-year to $320000.0, compared with a TTM value of $320000.0 through Dec 2025, up 685.03%, and an annual FY2025 reading of $320000.0, up 685.03% over the prior year.
  • Short-term Investments was $320000.0 for Q4 2025 at LifeMD, down from $370518.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.4 million in Q2 2021 and bottomed at $40763.0 in Q4 2024.
  • Average Short-term Investments over 5 years is $393333.6, with a median of $248639.5 recorded in 2023.
  • The sharpest move saw Short-term Investments tumbled 91.61% in 2024, then skyrocketed 685.03% in 2025.
  • Year by year, Short-term Investments stood at $203556.0 in 2021, then crashed by 37.48% to $127265.0 in 2022, then soared by 281.76% to $485850.0 in 2023, then crashed by 91.61% to $40763.0 in 2024, then surged by 685.03% to $320000.0 in 2025.
  • Business Quant data shows Short-term Investments for LFMD at $320000.0 in Q4 2025, $370518.0 in Q3 2025, and $251000.0 in Q2 2025.